Katie Macfarlane serves as Executive at CORTEX PHARMACEUTICALS INC/DE/, where they oversee executive responsibilities. Since joining the company, Katie Macfarlane has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 3, 2014 involved receiving (via award) 2,000,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 3, 2014 | CORX | $0 | Award | 2,000,000 | $N/A | Discretionary |
Katie Macfarlane currently holds 2,000,000 shares of CORTEX PHARMACEUTICALS INC/DE/ (CORX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Katie Macfarlane has been a net neutral trader of CORX stock. They have purchased $0 and sold $0 worth of shares.
Katie Macfarlane's most recent insider trade was on Sep 3, 2014, when they sold 2,000,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted